Selected research
Industry Research
Artemisinin Derivatives Industry Research Report 2026
Market perspective
The global Artemisinin Derivatives market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Artemisinin Derivatives is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Artemisinin Derivatives is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Artemisinin Derivatives is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Artemisinin Derivatives include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Artemisinin Derivatives market in revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Artemisinin Derivatives.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Artemisinin Derivatives Market by Company
Kerui Nanhai Pharmaceutical
Shanghai Natural Bio-engineering Co
Shanghai Natural Bio-engineering
Sanofi
Kunming Pharmaceutical
Kerui Nanhai
Guilin Pharmaceutical
Guangxi Xiancaotang Pharmaceutical
Guangxi Xiancaotang
Novanat Bioresource
KPC Pharmaceuticals
Botanical Extracts EPZ Ltd
ArtemiFlow
Artemisinin Derivatives Segment by Type
Dihydroartemisinin
Artemisunate
Others
Artemisinin Derivatives Segment by Application
Malaria Treatment
Scientific Research
Others
Artemisinin Derivatives Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artemisinin Derivatives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Artemisinin Derivatives and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artemisinin Derivatives.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Artemisinin Derivatives manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Artemisinin Derivatives by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Artemisinin Derivatives in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Dihydroartemisinin
- Artemisunate
- Others
Applications
- Malaria Treatment
- Scientific Research
- Others
Companies covered
- Kerui Nanhai Pharmaceutical
- Shanghai Natural Bio-engineering Co
- Shanghai Natural Bio-engineering
- Sanofi
- Kunming Pharmaceutical
- Kerui Nanhai
- Guilin Pharmaceutical
- Guangxi Xiancaotang Pharmaceutical
- Guangxi Xiancaotang
- Novanat Bioresource
- KPC Pharmaceuticals
- Botanical Extracts EPZ Ltd
- ArtemiFlow
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Artemisinin Derivatives by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Dihydroartemisinin
- 2.2.3 Artemisunate
- 2.2.4 Others
- 2.3 Artemisinin Derivatives by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Malaria Treatment
- 2.3.3 Scientific Research
- 2.3.4 Others
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Artemisinin Derivatives Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Artemisinin Derivatives Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Artemisinin Derivatives Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Artemisinin Derivatives Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Artemisinin Derivatives Production by Manufacturers (2021-2026)
- 3.2 Global Artemisinin Derivatives Production Value by Manufacturers (2021-2026)
- 3.3 Global Artemisinin Derivatives Average Price by Manufacturers (2021-2026)
- 3.4 Global Artemisinin Derivatives Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Artemisinin Derivatives Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Artemisinin Derivatives Manufacturers, Product Type & Application
- 3.7 Global Artemisinin Derivatives Manufacturers Established Date
- 3.8 Global Artemisinin Derivatives Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Kerui Nanhai Pharmaceutical
- 4.1.1 Kerui Nanhai Pharmaceutical Artemisinin Derivatives Company Information
- 4.1.2 Kerui Nanhai Pharmaceutical Artemisinin Derivatives Business Overview
- 4.1.3 Kerui Nanhai Pharmaceutical Artemisinin Derivatives Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Kerui Nanhai Pharmaceutical Product Portfolio
- 4.1.5 Kerui Nanhai Pharmaceutical Recent Developments
- 4.2 Shanghai Natural Bio-engineering Co
- 4.2.1 Shanghai Natural Bio-engineering Co Artemisinin Derivatives Company Information
- 4.2.2 Shanghai Natural Bio-engineering Co Artemisinin Derivatives Business Overview
- 4.2.3 Shanghai Natural Bio-engineering Co Artemisinin Derivatives Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Shanghai Natural Bio-engineering Co Product Portfolio
- 4.2.5 Shanghai Natural Bio-engineering Co Recent Developments
- 4.3 Shanghai Natural Bio-engineering
- 4.3.1 Shanghai Natural Bio-engineering Artemisinin Derivatives Company Information
- 4.3.2 Shanghai Natural Bio-engineering Artemisinin Derivatives Business Overview
- 4.3.3 Shanghai Natural Bio-engineering Artemisinin Derivatives Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Shanghai Natural Bio-engineering Product Portfolio
- 4.3.5 Shanghai Natural Bio-engineering Recent Developments
- 4.4 Sanofi
- 4.4.1 Sanofi Artemisinin Derivatives Company Information
- 4.4.2 Sanofi Artemisinin Derivatives Business Overview
- 4.4.3 Sanofi Artemisinin Derivatives Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Sanofi Product Portfolio
- 4.4.5 Sanofi Recent Developments
- 4.5 Kunming Pharmaceutical
- 4.5.1 Kunming Pharmaceutical Artemisinin Derivatives Company Information
- 4.5.2 Kunming Pharmaceutical Artemisinin Derivatives Business Overview
- 4.5.3 Kunming Pharmaceutical Artemisinin Derivatives Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Kunming Pharmaceutical Product Portfolio
- 4.5.5 Kunming Pharmaceutical Recent Developments
- 4.6 Kerui Nanhai
- 4.6.1 Kerui Nanhai Artemisinin Derivatives Company Information
- 4.6.2 Kerui Nanhai Artemisinin Derivatives Business Overview
- 4.6.3 Kerui Nanhai Artemisinin Derivatives Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Kerui Nanhai Product Portfolio
- 4.6.5 Kerui Nanhai Recent Developments
- 4.7 Guilin Pharmaceutical
- 4.7.1 Guilin Pharmaceutical Artemisinin Derivatives Company Information
- 4.7.2 Guilin Pharmaceutical Artemisinin Derivatives Business Overview
- 4.7.3 Guilin Pharmaceutical Artemisinin Derivatives Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Guilin Pharmaceutical Product Portfolio
- 4.7.5 Guilin Pharmaceutical Recent Developments
- 4.8 Guangxi Xiancaotang Pharmaceutical
- 4.8.1 Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Company Information
- 4.8.2 Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Business Overview
- 4.8.3 Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 Guangxi Xiancaotang Pharmaceutical Product Portfolio
- 4.8.5 Guangxi Xiancaotang Pharmaceutical Recent Developments
- 4.9 Guangxi Xiancaotang
- 4.9.1 Guangxi Xiancaotang Artemisinin Derivatives Company Information
- 4.9.2 Guangxi Xiancaotang Artemisinin Derivatives Business Overview
- 4.9.3 Guangxi Xiancaotang Artemisinin Derivatives Production Capacity, Value and Gross Margin (2021-2026)
- 4.9.4 Guangxi Xiancaotang Product Portfolio
- 4.9.5 Guangxi Xiancaotang Recent Developments
- 4.10 Novanat Bioresource
- 4.10.1 Novanat Bioresource Artemisinin Derivatives Company Information
- 4.10.2 Novanat Bioresource Artemisinin Derivatives Business Overview
- 4.10.3 Novanat Bioresource Artemisinin Derivatives Production Capacity, Value and Gross Margin (2021-2026)
- 4.10.4 Novanat Bioresource Product Portfolio
- 4.10.5 Novanat Bioresource Recent Developments
- 4.11 KPC Pharmaceuticals
- 4.11.1 KPC Pharmaceuticals Artemisinin Derivatives Company Information
- 4.11.2 KPC Pharmaceuticals Artemisinin Derivatives Business Overview
- 4.11.3 KPC Pharmaceuticals Artemisinin Derivatives Production Capacity, Value and Gross Margin (2021-2026)
- 4.11.4 KPC Pharmaceuticals Product Portfolio
- 4.11.5 KPC Pharmaceuticals Recent Developments
- 4.12 Botanical Extracts EPZ Ltd
- 4.12.1 Botanical Extracts EPZ Ltd Artemisinin Derivatives Company Information
- 4.12.2 Botanical Extracts EPZ Ltd Artemisinin Derivatives Business Overview
- 4.12.3 Botanical Extracts EPZ Ltd Artemisinin Derivatives Production Capacity, Value and Gross Margin (2021-2026)
- 4.12.4 Botanical Extracts EPZ Ltd Product Portfolio
- 4.12.5 Botanical Extracts EPZ Ltd Recent Developments
- 4.13 ArtemiFlow
- 4.13.1 ArtemiFlow Artemisinin Derivatives Company Information
- 4.13.2 ArtemiFlow Artemisinin Derivatives Business Overview
- 4.13.3 ArtemiFlow Artemisinin Derivatives Production Capacity, Value and Gross Margin (2021-2026)
- 4.13.4 ArtemiFlow Product Portfolio
- 4.13.5 ArtemiFlow Recent Developments
5 Global Artemisinin Derivatives Production by Region
- 5.1 Global Artemisinin Derivatives Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Artemisinin Derivatives Production by Region: 2021-2032
- 5.2.1 Global Artemisinin Derivatives Production by Region: 2021-2026
- 5.2.2 Global Artemisinin Derivatives Production Forecast by Region (2027-2032)
- 5.3 Global Artemisinin Derivatives Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Artemisinin Derivatives Production Value by Region: 2021-2032
- 5.4.1 Global Artemisinin Derivatives Production Value by Region: 2021-2026
- 5.4.2 Global Artemisinin Derivatives Production Value Forecast by Region (2027-2032)
- 5.5 Global Artemisinin Derivatives Market Price Analysis by Region (2021-2026)
- 5.6 Global Artemisinin Derivatives Production and Value, YOY Growth
- 5.6.1 North America Artemisinin Derivatives Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Artemisinin Derivatives Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Artemisinin Derivatives Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Artemisinin Derivatives Production Value Estimates and Forecasts (2021-2032)
6 Global Artemisinin Derivatives Consumption by Region
- 6.1 Global Artemisinin Derivatives Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Artemisinin Derivatives Consumption by Region (2021-2032)
- 6.2.1 Global Artemisinin Derivatives Consumption by Region: 2021-2026
- 6.2.2 Global Artemisinin Derivatives Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Artemisinin Derivatives Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Artemisinin Derivatives Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Artemisinin Derivatives Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Artemisinin Derivatives Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Artemisinin Derivatives Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Artemisinin Derivatives Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Artemisinin Derivatives Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Artemisinin Derivatives Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Artemisinin Derivatives Production by Type (2021-2032)
- 7.1.1 Global Artemisinin Derivatives Production by Type (2021-2032) & (t)
- 7.1.2 Global Artemisinin Derivatives Production Market Share by Type (2021-2032)
- 7.2 Global Artemisinin Derivatives Production Value by Type (2021-2032)
- 7.2.1 Global Artemisinin Derivatives Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Artemisinin Derivatives Production Value Market Share by Type (2021-2032)
- 7.3 Global Artemisinin Derivatives Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Artemisinin Derivatives Production by Application (2021-2032)
- 8.1.1 Global Artemisinin Derivatives Production by Application (2021-2032) & (t)
- 8.1.2 Global Artemisinin Derivatives Production Market Share by Application (2021-2032)
- 8.2 Global Artemisinin Derivatives Production Value by Application (2021-2032)
- 8.2.1 Global Artemisinin Derivatives Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Artemisinin Derivatives Production Value Market Share by Application (2021-2032)
- 8.3 Global Artemisinin Derivatives Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Artemisinin Derivatives Value Chain Analysis
- 9.1.1 Artemisinin Derivatives Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Artemisinin Derivatives Production Mode & Process
- 9.2 Artemisinin Derivatives Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Artemisinin Derivatives Distributors
- 9.2.3 Artemisinin Derivatives Customers
10 Global Artemisinin Derivatives Analyzing Market Dynamics
- 10.1 Artemisinin Derivatives Industry Trends
- 10.2 Artemisinin Derivatives Industry Drivers
- 10.3 Artemisinin Derivatives Industry Opportunities and Challenges
- 10.4 Artemisinin Derivatives Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst